Search

everythinglearnresearchcommunity

for

Search:↓

Treating excessive hair in women requires a holistic approach, including medical, aesthetic, and emotional support.

Finasteride side effects in young men may be linked to specific gene variations.

High levels of male hormones, insulin resistance, and obesity are closely linked and worsen polycystic ovary syndrome, but more research is needed to improve treatments.

Pregnant women with PCOS have higher levels of Neurokinin B in the placenta, especially with female babies.

Oxidative stress worsens PCOS by damaging cells and disrupting metabolism, suggesting antioxidant treatments might help.

Higher levels of ischemia-modified albumin in telogen effluvium patients may indicate oxidative stress.

A male with aromatase deficiency improved bone health with estradiol treatment.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Women with Polycystic Ovary Syndrome (PCOS) have lower levels of a substance called DIAPH1 in their blood, which is linked to changes in sugar metabolism and insulin resistance.

Only 22% of teenage girls in the study knew about PCOS, despite many having symptoms.

Myo-inositol and D-chiro-inositol improve hormonal and physical symptoms in teenage girls with PCOS.

Obesity can worsen wound healing by negatively affecting the function of stem cells in fat tissue.

Higher insulin levels are linked to larger ovaries in women with idiopathic hirsutism.

The conclusion is that the best approach for treating Female Pattern Hair Loss is a combination of different treatments.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Some conditions mimic PCOS symptoms and need careful diagnosis to treat potentially serious health issues.

Metformin improves hair growth and menstrual frequency in women with PCOS and hirsutism.

STK11 gene variations do not predict how well metformin will work for PCOS, but may affect hair loss and excess hair growth.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

ME1 and PPAR signaling may influence hair loss in androgenetic alopecia.

Insulin resistance is found in 20% of Thai women with PCOS, with age, waist size, skin changes, and abnormal blood fats increasing the risk.

Various treatments exist for hair loss, but more research is needed for better options.

Spironolactone is safe for breast cancer survivors with alopecia and does not increase cancer risk.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

Longer anogenital distance may indicate a higher chance of having polycystic ovary syndrome, and measuring this distance along with hormone levels could improve diagnosis.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

Leptin-deficient mice, used as a model for Type 2 Diabetes, have delayed wound healing due to impaired contraction and other dysfunctional cellular responses.

PCOS may have evolved as an advantage in past environments with food scarcity.

Oxidative stress may contribute to hair loss in alopecia areata and antioxidants could potentially help as a treatment.